Cartesian Therapeutics, Inc.
RNAC
$8.84
$0.121.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 15.77M | -39.18M | -92.58M | -35.90M | 15.89M |
| Total Depreciation and Amortization | 779.00K | 615.00K | 608.00K | 606.00K | 589.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.87M | 16.36M | 74.26M | 19.17M | -32.49M |
| Change in Net Operating Assets | 4.24M | 68.00K | -3.00K | 530.00K | -1.51M |
| Cash from Operations | -21.08M | -22.14M | -17.71M | -15.60M | -17.52M |
| Capital Expenditure | -272.00K | -27.00K | -492.00K | -1.29M | -2.60M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -272.00K | -27.00K | -492.00K | -1.29M | -2.60M |
| Total Debt Issued | 46.03M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.31M | 15.67M | 50.00K | 5.00K | 85.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -102.00K | -43.00K | -25.00K |
| Cash from Financing | 50.34M | 15.67M | -52.00K | -38.00K | 60.00K |
| Foreign Exchange rate Adjustments | -25.00K | -7.00K | 11.00K | -10.00K | 12.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.97M | -6.50M | -18.25M | -16.94M | -20.04M |